Warm Versus Conventional 2% Lignocaine for IANB Efficacy
Comparative Evaluation of Anesthetic Efficacy of Warm and Conventional 2% Lignocaine for the Success of Inferior Alveolar Nerve Block (IANB) in Mandibular Permanent Molars: A Randomized Controlled Clinical Trial
Armed Forces Institute of Dentistry, Pakistan
200 participants
Dec 15, 2024
INTERVENTIONAL
Conditions
Summary
The study compares the anesthetic efficacy of warm versus conventional 2% lignocaine for inferior alveolar nerve block in mandibular molars, evaluating success rates and onset time.
Eligibility
Inclusion Criteria5
- Permanent teeth with acutely inflamed pulp without swelling or draining sinus.
- Patient who have carious mandibular molars.
- Patients of either gender aged between 18-50 years old.
- Systemically healthy patients.
- Patients who agree to attend for recall appointments and provide a written consent
Exclusion Criteria6
- Patients on preoperative analgesics and antibiotics.
- Teeth with calcified canals and previously treated teeth.
- Pregnant and lactating mothers.
- Patients who are immunocompromised, anxious and mentally handicapped.
- Patients who are allergic to lignocaine.
- Non-vital or necrosed teeth.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
This study aims to compare the effectiveness of warm 2% lignocaine (lidocaine) versus conventional room temperature 2% lignocaine for achieving successful inferior alveolar nerve blocks (IANB) in mandibular permanent molars
This study aims to compare the effectiveness of warm 2% lignocaine (lidocaine) versus conventional room temperature 2% lignocaine for achieving successful inferior alveolar nerve blocks (IANB) in mandibular permanent molars
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06806202